Pediatric Cardiac Surgery

Compared with surgical ligation, transcatheter closure of the patent ductus arteriosus in infants and neonates was associated with reduced mortality rates and lower length of stay, researchers reported.

Published results showed Exparel may be safe in patients aged 6 to younger than 17 years undergoing spine or cardiac surgery.

The FDA announced it approved a self-expanding nonsurgical heart valve for pediatric and adult patients with a native or surgically repaired right ventricular outflow tract.

Abbott announced the FDA approved updated labeling for its implantable heart pump for use in pediatric patients with advanced refractory left ventricular HF.

Dexamethasone vs. placebo to reduce major complications and mortality during cardiac surgery in infants.

Interstage home monitoring programs for babies who underwent surgery due to heart defects reduced infant mortality by approximately 40%, according to a scientific statement from the American Heart Association.

There appears to be no increase in surgeries for congenital heart disease as a result of the 2011 Fukushima Daiichi nuclear accident, researchers reported.

Dexamethasone did not significantly reduce major complications and mortality at 30 days in infants who underwent cardiac surgery with cardiopulmonary bypass compared with placebo, according to findings from the DECISION trial.

Texas Children’s Hospital achieved the No. 1 rank on U.S. News & World Report’s list of best hospitals for pediatric cardiology and heart surgery for the fourth consecutive year.

Researchers of a published study found that, after cardiac surgery, children with congenital heart disease had an increased risk for both ESKD and mortality.